Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

Background: Antimalarial drugs were widely used as experimental therapies against COVID-19 in the initial stages of the pandemic. Despite multiple randomized controlled trials demonstrating unfavorable outcomes in both efficacy and adverse effects, antimalarial drugs are still prescribed in developi...

Descripció completa

Dades bibliogràfiques
Autors principals: Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, Sergio Rodríguez-Rodríguez, Jorge Carlos Oseguera-Moguel, Joel Dorantes-García, Clemente Barrón-Magdaleno, Aldo C Cázares-Diazleal, Carla Marina Román-Montes, Karla María Tamez-Torres, Bernardo Alfonso Martínez-Guerra, Alfonso Gulias-Herrero, María Fernanda González-Lara, Alfredo Ponce-de-León-Garduño, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio
Format: Article
Idioma:English
Publicat: Frontiers Media S.A. 2021-06-01
Col·lecció:Frontiers in Pharmacology
Matèries:
hydroxychloroquine
chloroquine
COVID-19
arrythmia
adverse-effects
antimalarial
Accés en línia:https://www.frontiersin.org/articles/10.3389/fphar.2021.668678/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.668678/full

Ítems similars